IART Q4 2017 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q4 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$369M+44.2% YoY

Gross Profit

$220M59.8% margin

Operating Income

$7M2.0% margin

Net Income

$44M12.0% margin

EPS (Diluted)

$0.56

QoQ Revenue Growth

+32.2%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

-$2M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$2.2B

Stockholders' Equity

$962M

Cash & Equivalents

$175M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$369M	$256M	+44.2%
Gross Profit	$220M	$170M	+29.5%
Operating Income	$7M	$41M	-82.3%
Net Income	$44M	$28M	+57.0%